Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies (Details Textual)

v3.7.0.1
Commitments and Contingencies (Details Textual) - USD ($)
 1 Months Ended 12 Months Ended
Jan. 14, 2017
Dec. 31, 2015
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2015
Dec. 30, 2013
Apr. 30, 2013
Commitments and Contingencies [Line Items]              
Research and Development Expense, Total     $ 4,117,000 $ 3,156,000      
Royalty Guarantees, Commitments, Amount     $ 200,000        
Long Term Purchase Commitment Expire Date     Dec. 31, 2015        
Operating Leases, Rent Expense     $ 2,100,000        
Commitments [Member]              
Commitments and Contingencies [Line Items]              
Research Services Agreements Value Fulfilling Commitment   $ 3,000,000          
License Costs $ 30,627            
Initial license fee 20,000            
Contractual Obligation, Due in Next Twelve Months           $ 78,000  
Contractual Obligation, Due in Second Year           $ 161,754  
Settlement Agreement [Member]              
Commitments and Contingencies [Line Items]              
Prepaid Expense             $ 1,000,000
Amended Agreement [Member]              
Commitments and Contingencies [Line Items]              
Research and Development Expense, Total         $ 2,100,000    
Second Eastern Affilate [Member]              
Commitments and Contingencies [Line Items]              
Research and Development Expense, Total       $ 565,000      
Minimum [Member] | Commitments [Member]              
Commitments and Contingencies [Line Items]              
License Costs 25,000            
Maximum [Member] | Commitments [Member]              
Commitments and Contingencies [Line Items]              
License Costs $ 150,000            
Fraunhofer [Member]              
Commitments and Contingencies [Line Items]              
Royalty Guarantees, Commitments, Amount   $ 3,000,000 $ 4,000,000        
Other Commitments, Description     the 2013 Settlement Agreement provided that, for a period of up to 15 years, the Company would pay Fraunhofer one percent (1%) of all receipts derived by the Company from sales of products produced utilizing the iBioLaunch or iBioModulator technology and ten percent (10%) of all receipts derived by the Company from licensing those technologies to third parties        
iBio CDMO [Member] | Second Eastern Affilate [Member]              
Commitments and Contingencies [Line Items]              
Operating Leases, Rent Expense     $ 15,370